Abiomed (ABMD) Tops Q3 EPS by 5c
Tweet
Share
E-mailGet Alerts ABMD Hot Sheet
Price: $381.02 --0%
Financial Fact:
Costs and Expenses, Total: 88.45M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Costs and Expenses, Total: 88.45M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Abiomed (NASDAQ: ABMD) reported Q3 EPS of $0.34, $0.05 better than the analyst estimate of $0.29. Revenue for the quarter came in at $114.7 million versus the consensus estimate of $112.71 million.
For earnings history and earnings-related data on Abiomed (ABMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Kodiak Sciences Inc. (KOD) Misses Q2 EPS by 7c
- Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
